Eyenovia announces independent director stephen benjamin to step down to assume role of head of white house's office of public engagement

New york, feb. 28, 2023 (globe newswire) -- eyenovia, inc. (nasdaq: eyen), a pre-commercial ophthalmic technology company developing the optejet® delivery system for use both in connection with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced that stephen benjamin, an independent director on the company's board of directors, is stepping down to assume the role of head of the white house's office of public engagement.
EYEN Ratings Summary
EYEN Quant Ranking